Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-47,461
Closed -$149K 1513
2025
Q4
$149K Buy
+47,461
New +$189K ﹤0.01% 1415
2024
Q4
Sell
-100,643
Closed -$552K 1459
2024
Q3
$552K Buy
+100,643
New +$753K ﹤0.01% 1155
2024
Q2
Sell
-1,670
Closed -$19K 1475
2024
Q1
$19K Sell
1,670
-2,028
-55% -$26.9K ﹤0.01% 1442
2023
Q4
$61K Sell
3,698
-45,643
-93% -$756K ﹤0.01% 1377
2023
Q3
$1.11M Sell
49,341
-36,398
-42% -$1.03M 0.01% 925
2023
Q2
$2.74M Buy
+85,739
New +$2.74M 0.02% 686
2022
Q4
Sell
-3,539
Closed -$142K 1593
2022
Q3
$142K Buy
3,539
+2,942
+493% +$150K ﹤0.01% 1700
2022
Q2
$23K Sell
597
-25,580
-98% -$929K ﹤0.01% 1845
2022
Q1
$1.26M Buy
26,177
+1,009
+4% +$54.5K 0.02% 1008
2021
Q4
$1.59M Buy
25,168
+23,632
+1,539% +$1.86M 0.02% 855
2021
Q3
$158K Buy
1,536
+339
+28% +$38.3K ﹤0.01% 1827
2021
Q2
$129K Buy
+1,197
New +$89.8K ﹤0.01% 2097
2020
Q3
Sell
-2,020
Closed -$156K 1699
2020
Q2
$156K Buy
+2,020
New +$121K ﹤0.01% 1568

Other funds holding AGEN

Michael Gelband's AGEN Position: Q1 2026 in Review

Michael Gelband sold out of Agenus (AGEN) in Q1 2026, closing a stake of 47,461 shares — an estimated $149K sold.

Michael Gelband first reported a position in AGEN in Q2 2020 and held it in 13 quarters. The position peaked at $2.74M in Q2 2023. 88 funds tracked by Wall St. Rank hold AGEN as of Q1 2026.

  • Michael Gelband reported no remaining Agenus position as of Q1 2026 after selling out during the quarter.
  • Michael Gelband sold 47,461 Agenus shares in Q1 2026, an estimated $149K.
  • Michael Gelband first reported a position in Agenus in Q2 2020 and held it in 13 quarters.
  • Michael Gelband's Agenus position peaked at $2.74M in Q2 2023.
  • 88 funds tracked by Wall St. Rank held Agenus as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.